Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.

NEWS & EVENTS

Outcome Measures and Infrastructure for Phase III Studies in Batten Disease, JNCL

Saturday, September 22, 2012 - Monday, September 24, 2012
Hyatt Regency, Atlanta, GA

The main objective of the meeting is to bring together clinical research experts in JNCL to focus, for the first time, on establishing common ground for outcomes and infrastructure in support of Phase III Clinical Trials. Towards this end, it is anticipated that at the end of the meeting the participants will be able to identify potential clinical trial endpoints for Juvenile Neuronal Ceroid Lipofuscinosis (JNCL, CLN3 disease, Batten Disease); build upon the infrastructure for an International Patient Registry for JNCL and other NCL diseases, and provide opportunities for junior investigators pursuing research in JNCL to learn about and participate in the clinical research development process.

Contact:
Dr. Danilo Tagle (301) 496-5745

Co-funding Institute(s):
National Institute of Neurological Disorders and Stroke
Office of Rare Diseases Research

From the National Center for Advancing Translational Sciences

From the National Institutes of Health

Connect with ORDR

See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.